2016~2023年全球10个主要国家心血管领域技术创新专利的现状分析和评价  

Analysis and Evaluation of the Status of Cardiovascular Patents in Ten Major Countries Worldwide From 2016 to 2023

作　　者：杨宁燕 刘欢梅 阎早芳 尹潞[2] 杨进刚[3] YANG Ningyan;LIU Huanmei;YAN Zaofang;YIN Lu;YANG Jingang(Scientific and Technological Achievement Transformation Office,National Center for Cardiovascular Diseases and Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China;National Clinical Research Center for Cardiovascular Diseases,National Center for Cardiovascular Diseases and Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 102308,China;Health Education Center,National Center for Cardiovascular Diseases and Fuwai Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China)

机构地区：[1]中国医学科学院,北京协和医学院,国家心血管病中心,阜外医院,科技成果转化办公室,北京100037 [2]中国医学科学院,北京协和医学院,国家心血管病中心,阜外医院,国家心血管疾病临床医学研究中心,北京102308 [3]中国医学科学院,北京协和医学院国家心血管病中心,健康教育中心,北京100037

出　　处：《中国循环杂志》2024年第10期956-967,共12页Chinese Circulation Journal

摘　　要：目的:比较2016~2023年全球10个主要国家心血管领域技术创新专利的保护和运用情况,评估我国心血管领域科技成果的相对竞争能力和创新能力,为提升科技成果的转移转化率提供参考。方法:利用HimmPat、IncoPat和智慧芽专利数据库,采用阜外心血管词表,通过国际专利分类(international patent classification,IPC)-标题-权利要求-摘要检索2016年1月1日至2023年12月31日全球10个主要国家在心血管领域专利申请数据,从专利技术价值、法律价值、经济价值三个维度下的具体指标进行比较分析。结果:从专利申请人地址的角度统计专利申请数据,以分析各国在心血管领域的技术创新能力,结果显示8年间中国在心血管领域的专利申请总数位居世界第二,约为46536件,仅次于美国的75382件;同族专利申请数量虽然高于美国(32879项vs.19587项),但中国进行海外布局的专利量仅占总体专利申请量的25.4%,只比俄罗斯高(15.5%),却远低于其他8个国家;在平均专利申请人数量方面,中国专利的平均申请人数仅为2.61位,而美国专利的平均申请人数为10.02位,德国为12.69位;在简单同族专利被引频次方面,美国为9.76次/项专利,中国仅为2.64次/项专利;中国的专利转化率也偏低,仅为7.3%。结论:我国心血管专利申请数量的不断攀升是我国经济发展、政府政策支持和科技进步共同作用的结果,但专利质量欠佳,海外布局明显不足,技术创新的横向合作不够,也可能是导致专利成果转化动能和效率不足的主要原因。Objectives:To compare the patent protection and application status of cardiovascular technology innovation in ten major countries worldwide from 2016 to 2023,and to analyze and evaluate the relative competitiveness and innovation ability of technology achievements in the cardiovascular fields in China,providing reference for improving the transfer and transformation rate of scientific and technological achievements in this field.Methods:Based on the HimmPat,IncoPat,and Wisdom Seed patent databases,using the Fuwai Subject Headings,we searched patent application data in the cardiovascular fields from ten major countries worldwide from January 1,2016 to December 31,2023 by adopting the method of the International Patent Classification(IPC)-Title-Claims-Abstract.We compared and analyzed specific indicators from the three dimensions of the patent,including technology value,legal value,and economic value.Results:Over the past eight years,the total number of patent applications in the cardiovascular fields was counted from the perspective of patent applicant addresses to analyze the technological innovation capabilities in cardiovascular field of each country.The results showed that China ranked the second in the world in terms of the total number of patent applications in the cardiovascular fields,with approximately 46536,followed the United States with 75382.Although the number of patent family applications in China is higher than that in the United States(32879 vs.19587),overseas applications for family patent in China only account for 25.4%of its total patent application volume,which is only higher than that in Russia(15.5%),while much lower than that in the other eight countries.In terms of the average number of patent applicants,there are only 2.61 applicants per patent in China,compared with 10.02 in the United States and 12.69 in Germany.In terms of citation frequency of simple patent family,the United States has 9.76 citations per patent,while China has only 2.64 citations per patent.Besides,the patent transfer

关 键 词：心血管专利 同族专利 授权率 有效率 失效率 专利转化 

分 类 号：R54[医药卫生—心血管疾病]